NY-ESO-1 specific antibodies are frequently detected in hight-risk myeloma.

被引:0
|
作者
van Rhee, F
Szmania, SM
Pomtree, M
Zhan, F
Moreno, A
Rosen, N
Fox, M
Barlogie, B
Shaughnessy, J
Batchu, R
Tricot, GJ
机构
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2464
引用
收藏
页码:676A / 676A
页数:1
相关论文
共 50 条
  • [21] DECITABINE PRIMES GLIOBLASTOMA TO NY-ESO-1 SPECIFIC T-CELL CYTOLYSIS VIA DNA DEMETHYLATION OF NY-ESO-1, CANCER-TESTIS ANTIGENS, AND PRO-INFLAMMATORY SIGNATURES
    Lai, Thomas
    Sun, Lu
    Treger, Janet
    Li, Tie
    Li, Kevin
    Prins, Terry
    Lai, Albert
    Prins, Robert
    Everson, Richard
    NEURO-ONCOLOGY, 2023, 25
  • [22] Recombinant vaccinia/fowipox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
    Jaeger, Elke
    Karbach, Julia
    Gnjatic, Sacha
    Neumann, Antje
    Bender, Armin
    Valmori, Danila
    Ayyoub, Maha
    Ritter, Erika
    Ritter, Gerd
    Jaeger, Dirk
    Panicali, Dennis
    Hoffman, Eric
    Pan, Linda
    Oettgen, Herbert
    Old, Lloyd J.
    Knuth, Alexander
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (39) : 14453 - 14458
  • [23] NY-ESO-1 specific CD4+ Thelper1 cells for immunotherapy of cancer
    Kayser, Simone
    Boss, Cristina
    Schumm, Michael
    Feucht, Judith
    Stevanovic, Stefan
    Lang, Peter
    Handgretinger, Rupert
    Garbe, Claus
    Roecken, Martin
    Feuchtinger, Tobias
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer
    Kawada, Junji
    Saito, Takuro
    Kurokawa, Yukinori
    Kawabata, Ryohei
    Takeno, Atsushi
    Takeoka, Tomohira
    Nose, Yohei
    Wada, Hisashi
    Eguchi, Hidetoshi
    Doki, Yuichiro
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024, 8 (02): : 243 - 250
  • [25] Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses
    Valmori, D
    Souleimanian, NE
    Hesdorffer, CS
    Ritter, G
    Old, LJ
    Ayyoub, M
    CLINICAL IMMUNOLOGY, 2005, 117 (01) : 24 - 30
  • [26] Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma
    Korangy, F
    Ormandy, LA
    Bleck, JS
    Klempnauer, A
    Wilkens, L
    Manns, MP
    Greten, TF
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4332 - 4341
  • [27] NY-ESO-1 TCR single edited t cells to treat multiple myeloma without inducing GvHD
    Mastaglio, S.
    Genovese, P.
    Magnani, Z.
    Landoni, E.
    Camisa, B.
    Schiroli, G.
    Provasi, E.
    Lombardo, A.
    Reik, A.
    Cieri, N.
    Rocchi, M.
    Oliveira, G.
    Escobar, G.
    Casucci, M.
    Gentner, B.
    Spinelli, A.
    Mondino, A.
    Bondanza, A.
    Vago, L.
    Ponzoni, M.
    Ciceri, F.
    Holmes, M.
    Naldini, L.
    Bonini, C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S102 - S102
  • [28] NOVEL HYPOMETHYLATING AGENT GSK-3484862 SENSITIZES GLIOBLASTOMA TO NY-ESO-1 SPECIFIC IMMUNOTHERAPY
    Li, Kevin
    Lai, Thomas
    Prins, Robert
    Everson, Richard
    NEURO-ONCOLOGY, 2023, 25
  • [29] Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
    Sabado, Rachel Lubong
    Pavlick, Anna
    Gnjatic, Sacha
    Cruz, Crystal M.
    Vengco, Isabelita
    Hasan, Farah
    Spadaccia, Meredith
    Darvishian, Farbod
    Chiriboga, Luis
    Holman, Rose Marie
    Escalon, Juliet
    Muren, Caroline
    Escano, Crystal
    Yepes, Ethel
    Sharpe, Dunbar
    Vasilakos, John P.
    Rolnitzsky, Linda
    Goldberg, Judith D.
    Mandeli, John
    Adams, Sylvia
    Jungbluth, Achim
    Pan, Linda
    Venhaus, Ralph
    Ott, Patrick A.
    Bhardwaj, Nina
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (03) : 278 - 287
  • [30] Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naive and memory NY-ESO1-specific CD8+ T cells
    Masterman, Kelly-Anne
    Haigh, Oscar L.
    Tullett, Kirsteen M.
    Leal-Rojas, Ingrid M.
    Walpole, Carina
    Pearson, Frances E.
    Cebon, Jonathon
    Schmidt, Christopher
    O'Brien, Liam
    Rosendahl, Nikita
    Daraj, Ghazal
    Caminschi, Irina
    Gschweng, Eric H.
    Hollis, Roger P.
    Kohn, Donald B.
    Lahoud, Mireille H.
    Radford, Kristen J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)